Gunaydin, Y. Et Al. 2013. Biweekly cisplatin and gemcitabine as first line treatment in stage IV non-small cell lung cancer. European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO , (Amsterdam, Netherlands).

Gunaydin, Y., Benekli, M., Inanc, M., Ozkan, M., Demirci, A., Demirci, U., ... Suner, A.(2013). Biweekly cisplatin and gemcitabine as first line treatment in stage IV non-small cell lung cancer . European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, Amsterdam, Netherlands

Gunaydin, Y. Et Al. "Biweekly cisplatin and gemcitabine as first line treatment in stage IV non-small cell lung cancer," European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, Amsterdam, Netherlands, 2013

Gunaydin, Y. Et Al. "Biweekly cisplatin and gemcitabine as first line treatment in stage IV non-small cell lung cancer." European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO , Amsterdam, Netherlands, 2013

Gunaydin, Y. Et Al. (2013) . "Biweekly cisplatin and gemcitabine as first line treatment in stage IV non-small cell lung cancer." European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO , Amsterdam, Netherlands.

@conferencepaper{conferencepaper, author={Y. Gunaydin Et Al. }, title={Biweekly cisplatin and gemcitabine as first line treatment in stage IV non-small cell lung cancer}, congress name={European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO}, city={Amsterdam}, country={Netherlands}, year={2013}}